Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About AAC
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • AAC Podcast
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Antimicrobial Agents and Chemotherapy
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About AAC
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • AAC Podcast
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
Mechanisms of Action: Physiological Effects

In Vivo and In Vitro Patterns of the Activity of Simocyclinone D8, an Angucyclinone Antibiotic from Streptomyces antibioticus

Lisa M. Oppegard, Bree L. Hamann, Kathryn R. Streck, Keith C. Ellis, Hans-Peter Fiedler, Arkady B. Khodursky, Hiroshi Hiasa
Lisa M. Oppegard
1Department of Pharmacology, University of Minnesota Medical School—Twin Cities, Minneapolis, Minnesota 55455
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bree L. Hamann
2Department of Biochemistry, Molecular Biology, and Biophysics and Biotechnology Institute, University of Minnesota, St. Paul, Minnesota 55108
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kathryn R. Streck
1Department of Pharmacology, University of Minnesota Medical School—Twin Cities, Minneapolis, Minnesota 55455
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Keith C. Ellis
3Department of Medicinal Chemistry and Institute for Therapeutic Discovery and Development, College of Pharmacy, University of Minnesota, Minneapolis, Minnesota 55414
4Department of Medicinal Chemistry, School of Pharmacy, Virginia Commonwealth University, Richmond, Virginia 23298
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hans-Peter Fiedler
5Mikrobiologisches Institut, Universität Tübingen, Auf der Morgenstelle 28, D-72076 Tübingen, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Arkady B. Khodursky
2Department of Biochemistry, Molecular Biology, and Biophysics and Biotechnology Institute, University of Minnesota, St. Paul, Minnesota 55108
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hiroshi Hiasa
1Department of Pharmacology, University of Minnesota Medical School—Twin Cities, Minneapolis, Minnesota 55455
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: hiasa001@umn.edu
DOI: 10.1128/AAC.01440-08
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Additional Files
  • FIG. 1.
    • Open in new tab
    • Download powerpoint
    FIG. 1.

    Structure of SD8. Two functional groups, the aminocoumarin and the glycone, are shown. The calculated molecular mass of SD8 is 932.2169, whereas the molecular masses, determined by mass spectrometry, of the original and current preparations of SD8 are 932.2134 and 932.2139, respectively. Me, methyl.

  • FIG. 2.
    • Open in new tab
    • Download powerpoint
    FIG. 2.

    SD8 is a potent inhibitor of S. aureus gyrase. The supercoiling reaction mixtures containing the relaxed DNA, either 50 fmol of S. aureus (Sa) gyrase (A) or 10 fmol of E. coli (Ec) gyrase (B), and the indicated concentrations of either SD8 or ciprofloxacin (Cipro) were incubated, and the DNA products were analyzed as described in Materials and Methods. Lanes 1 and 2 contain controls with gyrase and drug present (+) or absent (−). The arrows in panels A and B show that gyrase was present in lanes 3 to 13.

  • FIG. 3.
    • Open in new tab
    • Download powerpoint
    FIG. 3.

    The presence of KGlu affects the apparent SD8 sensitivity of S. aureus gyrase in the DNA cleavage assay. The two-step DNA cleavage assay was performed as described in Materials and Methods. (A) For E. coli (Ec) gyrase, 50 fmol of E. coli gyrase, the supercoiled DNA, and the indicated concentrations of SD8 were first incubated, and then 10 μM of ciprofloxacin (Cipro) was added to the reaction mixtures. (B and C) For S. aureus (Sa) gyrase, 400 fmol of S. aureus gyrase, the supercoiled DNA, and the indicated concentrations of SD8 were first incubated in the absence (B) or presence (C) of 400 mM KGlu, and then 50 μM of ciprofloxacin was added to the reaction mixtures. No EtBr was included in the TAE buffer. Lanes 1 and 2 contain controls with gyrase and drug present (+) or absent (− and 0). The arrows in panels A, B, and C show that gyrase was present in lanes 3 to 9 or 10.

  • FIG. 4.
    • Open in new tab
    • Download powerpoint
    FIG. 4.

    Effects of SD8 on the decatenation activity of Topo IV. The decatenation reaction mixtures containing kinetoplast DNA, 50 fmol of either S. aureus (Sa) Topo IV (A) or E. coli (Ec) Topo IV (B), and the indicated concentrations of either SD8 or ciprofloxacin (Cipro) were incubated, and the DNA products were analyzed as described in Materials and Methods. Lanes 1 and 2 contain controls with Topo IV and drug present (+) or absent (− and 0). The arrows in panels A and B show that Topo IV was present in lanes 3 to 12.

  • FIG. 5.
    • Open in new tab
    • Download powerpoint
    FIG. 5.

    Effect of SD8 on growth of wild-type and ΔacrB strains. Absorbance (Abs) over time at 600 nm of wild-type (A) and ΔacrB (B) cultures treated with various concentrations of SD8 recorded in a 96-well format. The error bars represent 1 standard deviation of measurements done in triplicate. The cells were treated with SD8 (D8) concentrations ranging from 10 nM to 50 μM; however, only results from 1 μM to 50 μM are depicted, as there was little difference in the growth pattern of cells treated with <1 μM SD8.

  • FIG. 6.
    • Open in new tab
    • Download powerpoint
    FIG. 6.

    Transcriptional profile of SD8 treatment is most similar to the profile of gyrase inhibition. For the set of genes significantly affected by SD8 treatment, the Pearson correlation coefficients between the vector obtained in SD8 treatment and each of the 198 microarray conditions were calculated and plotted in descending order.

  • FIG. 7.
    • Open in new tab
    • Download powerpoint
    FIG. 7.

    Surface antigen and DNA replication genes are similarly upregulated by SD8 and novobiocin. Pairwise correlations between profiles (expressed as one-dimensional vectors of log-transformed ratios of transcript abundances) of genes encoding DNA replication proteins and of genes encoding surface antigens. The reference treatments are indicated along the x axes. In Fig. 7 to 9, only the genes that were identified as significantly affected at a median false discovery rate of 5% or less are labeled.

  • FIG. 8.
    • Open in new tab
    • Download powerpoint
    FIG. 8.

    The pattern of SD8 activity shares limited similarity with transcriptional patterns of the norfloxacin effect. The characteristic profiles of norfloxacin treatment, the induction of the SOS response, upregulation of the TCA cycle genes, and downregulation of genes encoding components of the citrate-dependent iron transport system, were compared with those of SD8 treatment. Pairwise correlations between profiles of gene classes are shown as described in the legend to Fig. 7.

  • FIG. 9.
    • Open in new tab
    • Download powerpoint
    FIG. 9.

    The pattern of SD8 activity shares limited similarity with transcriptional patterns of the novobiocin effect. The transcriptional signatures of the novobiocin effect, the induction of RpoH targets, upregulation of relaxation-sensitive genes, and downregulation of supercoiling-sensitive genes, were compared with those of the SD8 treatment. Pairwise correlations between profiles of gene classes are shown as described in the legend to Fig. 7.

  • FIG. 10.
    • Open in new tab
    • Download powerpoint
    FIG. 10.

    Effect of SD8 on nucleoid morphology. Exponentially grown ΔacrB cells were treated with either SD8 or DMSO, the solvent of SD8, stained with DAPI, and visualized by fluorescence (A, B, E, and F) and phase-contrast (C, D, G, and H) microscopy.

Tables

  • Figures
  • Additional Files
  • TABLE 1.

    Drug sensitivities of S. aureus and E. coli topoisomerasesa

    TopoisomeraseIC50 (μM) of topoisomerase
    SD8Ciprofloxacin
    S. aureus gyrase1.45 ± 0.3548 ± 9
    E. coli gyrase0.41 ± 0.032.35 ± 0.55
    S. aureus Topo IV14.5 ± 0.58.4 ± 0.1
    E. coli Topo IV270 ± 1034 ± 1
    • ↵ a The drug sensitivities of gyrases and Topo IVs were measured in the supercoiling and decatenation assays, respectively. Each assay was repeated two or three times, and the IC50s were determined based on the amounts of either the supercoiled DNA or decatenated DNA. Representative results are shown in Fig. 2 and 4.

Additional Files

  • Figures
  • Tables
  • Supplemental material

    Files in this Data Supplement:

    • Supplemental file 1 - NMR studies of SD8.
      TIFF file, 6.5MB.
    • Supplemental file 2 - Effects of SD8 on Ec gyrase.
      TIFF file, 6.6MB.
    • Supplemental file 3 - Effect of KGlu on the apparent SD8 sensitivity of Sa Topo IV in the DNA cleavage assay.
      TIFF file, 5.4MB.
    • Supplemental file 4 - Elongation of cells caused by SD8 treatment.
      TIFF file, 5.2MB.
    • Supplemental file 5 - Effect of SD8 on the cleavage activity of DNA gyrase in vitro.
      TIFF file, 4.75MB.
    • Supplemental file 6 - Text description of the characterization of SD8, plus two supplemental tables.
      MS Word document, 293K.
PreviousNext
Back to top
Download PDF
Citation Tools
In Vivo and In Vitro Patterns of the Activity of Simocyclinone D8, an Angucyclinone Antibiotic from Streptomyces antibioticus
Lisa M. Oppegard, Bree L. Hamann, Kathryn R. Streck, Keith C. Ellis, Hans-Peter Fiedler, Arkady B. Khodursky, Hiroshi Hiasa
Antimicrobial Agents and Chemotherapy Apr 2009, 53 (5) 2110-2119; DOI: 10.1128/AAC.01440-08

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Antimicrobial Agents and Chemotherapy article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
In Vivo and In Vitro Patterns of the Activity of Simocyclinone D8, an Angucyclinone Antibiotic from Streptomyces antibioticus
(Your Name) has forwarded a page to you from Antimicrobial Agents and Chemotherapy
(Your Name) thought you would be interested in this article in Antimicrobial Agents and Chemotherapy.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
In Vivo and In Vitro Patterns of the Activity of Simocyclinone D8, an Angucyclinone Antibiotic from Streptomyces antibioticus
Lisa M. Oppegard, Bree L. Hamann, Kathryn R. Streck, Keith C. Ellis, Hans-Peter Fiedler, Arkady B. Khodursky, Hiroshi Hiasa
Antimicrobial Agents and Chemotherapy Apr 2009, 53 (5) 2110-2119; DOI: 10.1128/AAC.01440-08
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • ACKNOWLEDGMENTS
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

KEYWORDS

Anti-Bacterial Agents
Escherichia coli
Staphylococcus aureus
Streptomyces antibioticus

Related Articles

Cited By...

About

  • About AAC
  • Editor in Chief
  • Editorial Board
  • Policies
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • AAC Podcast
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Ethics
  • Contact Us

Follow #AACJournal

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0066-4804; Online ISSN: 1098-6596